Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Practical Polling for Prostate Cancer: AR-V7–based Treatment Selection — Alastair Lamb (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Practical Polling for Prostate Cancer: AR-V7–based Treatment Selection
Shared by
Shahneen Sandhu
University of Melbourne
Practical Polling for Prostate Cancer: AR-V7–based Treatment Selection
Letter
2017
en
Authors
AL
Alastair Lamb
ML
Mitchell G. Lawrence
Shahneen Sandhu
University of Melbourne
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Preprint
2023
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
A. M. Mahedi Hasan
,
Paolo Cremaschi
,
Daniel Wetterskog
,
Anuradha Jayaram
,
Stephen Q. Wong
,
Scott Williams
,
Anupama Pasam
,
Anna Trigos
,
Blanca Trujillo
,
Emily Grist
,
Stefanie Friedrich
,
Osvaldas Vainauskas
,
Marina Parry
,
Mazlina Ismail
,
Wout Devlies
,
Anna Wingate
,
Stefano Lise
,
Shahneen Sandhu
,
Gerhardt Attard
Preprint
2022
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
A. M. Mahedi Hasan
,
Paolo Cremaschi
,
Daniel Wetterskog
,
Anuradha Jayaram
,
Stephen Q. Wong
,
Scott Williams
,
Anupama Pasam
,
Anna Trigos
,
Blanca Trujillo
,
Emily Grist
,
Stefanie Friedrich
,
Osvaldas Vainauskas
,
Marina Parry
,
Mazlina Ismail
,
Wout Devlies
,
Anna Wingate
,
Stefano Lise
,
Shahneen Sandhu
,
Gerhardt Attard
Editorial Material
2008
Editorial Comment on: New treatment approaches for prostate cancer based on peptide analogues
Aristotelis Bamias
,
Meletios A Dimopoulos
Article
2010
Horizon scanning for novel therapeutics for the treatment of prostate cancer
Diletta Bianchini
,
Andrea Zivi
,
Shahneen Sandhu
,
Johann S. de Bono
Article
2010
RETRACTED: Horizon scanning for novel therapeutics for the treatment of prostate cancer
Diletta Bianchini
,
Andrea Zivi
,
Shahneen Sandhu
,
Johann S. de Bono
Discussion(0)
No comments yet. Be the first to comment.